Syndax Pharmaceuticals , a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, ...
Novo Nordisk announced today that Wegovy® (semaglutide injection) is now approved to reduce the risk of non-fatal myocardial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback